合成生物学の世界市場

◆英語タイトル:Global Synthetic Biology Industry

Global Industry Analystsが発行した調査報告書(GIA21AP056)◆商品コード:GIA21AP056
◆発行会社(リサーチ会社):Global Industry Analysts
◆発行日:2021年4月
◆ページ数:435
◆レポート形式:英語 / PDF(印刷不可)
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single UserUSD5,450 ⇒換算¥806,600見積依頼/購入/質問フォーム
Five UserUSD7,630 ⇒換算¥1,129,240見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

As a Wiser World Looks to Make a Strong Sustainable Recovery From COVID-19, Synthetic Biology to Receive New Opportunities for Growth. Market to Reach $33.2 Billion.- The global market for Synthetic Biology is projected to reach US$33.2 billion by the year 2027, trailing a post COVID-19 CAGR of 25.2%, over the analysis period 2020 through 2027. With humans continuing their mindless plunder of the planet, natural habitat destruction and climate change has already set the stage for an era of pandemics. Animal-borne infectious diseases will continue to rise in the coming years, as human become the new host for displaced animal viruses. The current scenario has amplified the urgency to address environmental issues & ensure strict compliance among polluting businesses. Synthetic biology unfolds a new scientific era, in which synthetic organisms can be created to serve different purposes. The new biological research area is a nascent science and engineering discipline that seeks to integrate science with engineering for designing and building novel biological entities, including cells, genetic circuits and enzymes, or for redesigning active biological systems and living organisms, such as bacteria inexpensively and rapidly. Synthetic biology has already come out of the lab, buoyed by significant investments both from private and public organizations in organisms synthesized to produce chemicals, materials, medicines and biofuels. Synthetic biology derives its existence from advances in the fields of molecular biology, nanotechnology, engineering, chemistry, physics and computer science.
- Synthetic biology enables the development of standardized and interchangeable DNA strands, which do not exist in the natural world. Synthetic biology techniques create base pair sequences from component parts, and assemble them from the beginning. This field of engineering organisms at the molecular level offers enormous potential and scope. In recent years the field of synthetic biology witnessed rapid development due to the development of CRISPR-Cas9, a gene editing tool, which was first introduced in the year 2013. This tool enables in locating, cutting, and replacing DNA at certain specific locations. Synthetic biology is expected to create huge generic capabilities to be used in bio-inspired processes and tools applicable in the industry along with the whole economy. The approach holds a tremendous potential to assist researchers in designing, creating and testing systems, parts and even entire set of genomes. While genetic sequencing is associated with reading DNA, and genetic engineering is related to copy, cut and paste these DNAs, synthetic biology involves writing as well as programming DNAs to build genomes from the scratch and understand how life works. Synthetic biology can be applied to a large number of industrial segments, and holds potential to develop spectacular systems and processes such as nitrogen fixation and create edible wonder protein with various essential amino acids. In near future, majority of research activities in this field are expected to focus on energy products, chemicals, pharmaceuticals and diagnostic tools. In addition, the concept is anticipated to play a major role in addressing concerns associated with energy, water and cultivable land to reduce carbon footprint and drastically change the way people farm and eat.
- With the U.S. leading the way, sustainable products are poised to emerge into a big global opportunity. From sustainable chemistry to renewable energy & biofuels, synthetic biology holds the potential to eliminate market barriers to developing sustainable, environment friendly products, materials & services. Interestingly, the global COVID-19 pandemic has opened opportunities for new approaches and accelerated several innovative trends that were already underway. During the early stages of the global COVID-19 outbreak, 3D printing or additive manufacturing was found to play an important role in urgently producing much needed personal protective equipment and ventilator equipment locally for bridging the shortage caused by disruptions in global supply chains. The world is also now looking for ways of developing vaccines and treatments for coronavirus, which is where synthetic biology can contribute at a much faster pace as compared to conventional approaches. Synthetic biology’s toolset seems poised to create vaccines as well as treatments that are not only more potent and stable, but also are quicker and easier to manufacture. These benefits are extremely critical in addressing the existing health crisis as well as enabling health systems and governments to quickly respond to any unanticipated and new future threats. While synthetic biology has been for long bringing profound changes to the process of producing chemicals, materials, and food, as well as helping addressing other major global challenges, such as food security, chronic disease, and climate change, it is the COVID-19 pandemic that could eventually provide a breakout moment for synthetic biology.

- Select Competitors (Total 134 Featured) -
Agilent Technologies, Inc
Amyris, Inc
Arzeda
Atum
Eurofins Genomics Blue Heron LLC
Codexis, Inc
Creative Enzymes
Cyrus Biotechnology, Inc
Editas Medicine, Inc
Eurofins Scientific
GENEWIZ, Inc
GeneWorks Pty Ltd
Genscript Biotech Corporation
Ginkgo Bioworks
Integrated Dna Technologies, Inc
New England Biolabs
Novozymes A/S
OriGene Technologies, Inc
Proterro, Inc
Synthego Corporation
Synthetic Genomics, Inc. (SGI)
Synthorx, Inc
TeselaGen Biotechnology Inc
Thermo Fisher Scientific, Inc
Twist Bioscience

❖ レポートの目次 ❖

I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
COVID-19 Pandemic Poised to Drive Demand for Synthetic Biology
EXHIBIT 1: COVID-19 Vaccines in Pipeline by Technology
Synthetic Biologists Create Slow-Growing Version of COVID-19 as Vaccine Candidate
Role of Synthetic Biology in Combating COVID-19
Synthetic Biology: A Prelude
Growing Importance of Synthetic Biology
Applications of Synthetic Biology
Synthetic Biology Tools
Technologies Involved
Market Outlook
Regional Landscape
Major Challenges and Concerns
Teeming R&D Funding & Potential to Alter Molecular Landscape Enable Global Synthetic Biology Market to Remain in High Spirits
Competitive Landscape
Major Players by Industry Verticals
Synthetic Biology Startups Get Aggressive on Bioengineered Product Commercialization
Compelling Breakthroughs Drive Funding
Top Funded Synthetic Biology Startups in Q2 2020
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Synthetic Biology Market Witnesses Significant Rise in Investments
Importance of Synthetic Biology for Investments
Efforts from Leading Players Bodes Well for Market Growth
Patent Landscape Gets Richer
Synthetic Biology Patent Landscape by Assignee Countries (in %) : 2003-2018
Top 15 Patent Assignees in Synthetic Biology Domain: 2003-2018
Select Patent Assignees for Synthetic Biology in the US: 2019
Robotics and Workflow Automation Support Market Expansion
Advancements in Instrumentation Augurs Well
Improvements in Computer-Aided Biology
Fusion of AI and Synthetic Biology Expands Opportunities
Synthetic Biology Brings a Paradigm Shift in the Field of Biological Research
DNA Sequencing Plays an Important Role
Plummeting Cost of DNA Sequencing Bolsters Market Growth
EXHIBIT 2: Cost per Genome Sequencing: 2001-2020
Food Scarcity to Fuel Synthetic Biology Application in Agriculture
Select Companies Engaged in Making Food Using Synthetic Biology
Synthetic Biology Aids in Development of Exotic and Artificially Grown Meats and Proteins to Meet Future Food Demand
Growing Demand for GM Crops Opens Up Growth Avenues
Synthetic Biology-based Ingredients Gain Traction
Role of Synthetic Biology in Producing Plants with Desirable Characteristics
Synthetic Biology Gains Prominence in Biomedical Applications
Synthetic Genes Open up a New World of Drug Development
Synthetic Biology to Transform Healthcare with Captivating Advances in Biomedicine
Synthetic Biology Enables Creation of Advanced Biosensing Systems
Synthetic Biology Gains Significance in Production of Bio-Based Chemicals and Biofuels
EXHIBIT 3: Global Biofuels Market in US$ Billion: 2019 and 2024
Synthetic Biology Gains Importance as Focus on Carbon Recycling Increases
Synthetic Biology Disrupts the Cosmetics Sector
Capability of Synthetic Biology in Environmental Applications
Synthetic Biology Creates Buzz as Key Enabler of Exciting & Dynamic Applications for Diverse Domains
Synthetic Biology for Advanced, Multifunctional Materials
Genetically Engineered Fabrics and Sustainable Dyes Using Synthetic Biology to Transform Textile Industry
EXHIBIT 4: Select Synthetic Biology Offerings in Textile Industry
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Current & Future Analysis for Synthetic Biology by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Synthetic Biology by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 3: World 12-Year Perspective for Synthetic Biology by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2020 & 2027
TABLE 4: World Current & Future Analysis for Oligonucleotides & Synthetic DNA by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Oligonucleotides & Synthetic DNA by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 6: World 12-Year Perspective for Oligonucleotides & Synthetic DNA by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
TABLE 7: World Current & Future Analysis for Enzymes by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Enzymes by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 9: World 12-Year Perspective for Enzymes by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
TABLE 10: World Current & Future Analysis for Cloning Technology Kits by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Cloning Technology Kits by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 12: World 12-Year Perspective for Cloning Technology Kits by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
TABLE 13: World Current & Future Analysis for Synthetic Cells by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Synthetic Cells by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 15: World 12-Year Perspective for Synthetic Cells by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
TABLE 16: World Current & Future Analysis for Xeno-Nucleic Acids (XNA) by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Xeno-Nucleic Acids (XNA) by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 18: World 12-Year Perspective for Xeno-Nucleic Acids (XNA) by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
TABLE 19: World Current & Future Analysis for Chassis Organism by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Chassis Organism by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 21: World 12-Year Perspective for Chassis Organism by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
TABLE 22: World Current & Future Analysis for Nucleotide Synthesis & Sequencing by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Nucleotide Synthesis & Sequencing by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 24: World 12-Year Perspective for Nucleotide Synthesis & Sequencing by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
TABLE 25: World Current & Future Analysis for Genome Engineering by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Genome Engineering by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 27: World 12-Year Perspective for Genome Engineering by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
TABLE 28: World Current & Future Analysis for Microfluidics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 29: World Historic Review for Microfluidics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 30: World 12-Year Perspective for Microfluidics by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
TABLE 31: World Current & Future Analysis for Other Technologies by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 32: World Historic Review for Other Technologies by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 33: World 12-Year Perspective for Other Technologies by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
TABLE 34: World Current & Future Analysis for Pharmaceuticals & Diagnostics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 35: World Historic Review for Pharmaceuticals & Diagnostics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 36: World 12-Year Perspective for Pharmaceuticals & Diagnostics by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
TABLE 37: World Current & Future Analysis for Industrial by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 38: World Historic Review for Industrial by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 39: World 12-Year Perspective for Industrial by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
TABLE 40: World Current & Future Analysis for Food & Agriculture by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 41: World Historic Review for Food & Agriculture by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 42: World 12-Year Perspective for Food & Agriculture by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
TABLE 43: World Current & Future Analysis for Environmental by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 44: World Historic Review for Environmental by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 45: World 12-Year Perspective for Environmental by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
TABLE 46: World Current & Future Analysis for Other Applications by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 47: World Historic Review for Other Applications by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 48: World 12-Year Perspective for Other Applications by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
TABLE 49: USA Current & Future Analysis for Synthetic Biology by Tool – Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 50: USA Historic Review for Synthetic Biology by Tool – Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 51: USA 12-Year Perspective for Synthetic Biology by Tool – Percentage Breakdown of Value Sales for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2020 & 2027
TABLE 52: USA Current & Future Analysis for Synthetic Biology by Technology – Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: USA Historic Review for Synthetic Biology by Technology – Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 54: USA 12-Year Perspective for Synthetic Biology by Technology – Percentage Breakdown of Value Sales for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2020 & 2027
TABLE 55: USA Current & Future Analysis for Synthetic Biology by Application – Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: USA Historic Review for Synthetic Biology by Application – Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 57: USA 12-Year Perspective for Synthetic Biology by Application – Percentage Breakdown of Value Sales for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2020 & 2027
CANADA
TABLE 58: Canada Current & Future Analysis for Synthetic Biology by Tool – Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: Canada Historic Review for Synthetic Biology by Tool – Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 60: Canada 12-Year Perspective for Synthetic Biology by Tool – Percentage Breakdown of Value Sales for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2020 & 2027
TABLE 61: Canada Current & Future Analysis for Synthetic Biology by Technology – Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: Canada Historic Review for Synthetic Biology by Technology – Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 63: Canada 12-Year Perspective for Synthetic Biology by Technology – Percentage Breakdown of Value Sales for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2020 & 2027
TABLE 64: Canada Current & Future Analysis for Synthetic Biology by Application – Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 65: Canada Historic Review for Synthetic Biology by Application – Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 66: Canada 12-Year Perspective for Synthetic Biology by Application – Percentage Breakdown of Value Sales for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2020 & 2027
JAPAN
TABLE 67: Japan Current & Future Analysis for Synthetic Biology by Tool – Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: Japan Historic Review for Synthetic Biology by Tool – Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 69: Japan 12-Year Perspective for Synthetic Biology by Tool – Percentage Breakdown of Value Sales for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2020 & 2027
TABLE 70: Japan Current & Future Analysis for Synthetic Biology by Technology – Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Japan Historic Review for Synthetic Biology by Technology – Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 72: Japan 12-Year Perspective for Synthetic Biology by Technology – Percentage Breakdown of Value Sales for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2020 & 2027
TABLE 73: Japan Current & Future Analysis for Synthetic Biology by Application – Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: Japan Historic Review for Synthetic Biology by Application – Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 75: Japan 12-Year Perspective for Synthetic Biology by Application – Percentage Breakdown of Value Sales for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2020 & 2027
CHINA
TABLE 76: China Current & Future Analysis for Synthetic Biology by Tool – Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: China Historic Review for Synthetic Biology by Tool – Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 78: China 12-Year Perspective for Synthetic Biology by Tool – Percentage Breakdown of Value Sales for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2020 & 2027
TABLE 79: China Current & Future Analysis for Synthetic Biology by Technology – Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: China Historic Review for Synthetic Biology by Technology – Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 81: China 12-Year Perspective for Synthetic Biology by Technology – Percentage Breakdown of Value Sales for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2020 & 2027
TABLE 82: China Current & Future Analysis for Synthetic Biology by Application – Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: China Historic Review for Synthetic Biology by Application – Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 84: China 12-Year Perspective for Synthetic Biology by Application – Percentage Breakdown of Value Sales for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2020 & 2027
EUROPE
TABLE 85: Europe Current & Future Analysis for Synthetic Biology by Geographic Region – France, Germany, Italy, UK and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 86: Europe Historic Review for Synthetic Biology by Geographic Region – France, Germany, Italy, UK and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 87: Europe 12-Year Perspective for Synthetic Biology by Geographic Region – Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2020 & 2027
TABLE 88: Europe Current & Future Analysis for Synthetic Biology by Tool – Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Europe Historic Review for Synthetic Biology by Tool – Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 90: Europe 12-Year Perspective for Synthetic Biology by Tool – Percentage Breakdown of Value Sales for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2020 & 2027
TABLE 91: Europe Current & Future Analysis for Synthetic Biology by Technology – Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: Europe Historic Review for Synthetic Biology by Technology – Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 93: Europe 12-Year Perspective for Synthetic Biology by Technology – Percentage Breakdown of Value Sales for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2020 & 2027
TABLE 94: Europe Current & Future Analysis for Synthetic Biology by Application – Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Europe Historic Review for Synthetic Biology by Application – Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 96: Europe 12-Year Perspective for Synthetic Biology by Application – Percentage Breakdown of Value Sales for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2020 & 2027
FRANCE
TABLE 97: France Current & Future Analysis for Synthetic Biology by Tool – Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: France Historic Review for Synthetic Biology by Tool – Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 99: France 12-Year Perspective for Synthetic Biology by Tool – Percentage Breakdown of Value Sales for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2020 & 2027
TABLE 100: France Current & Future Analysis for Synthetic Biology by Technology – Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 合成生物学の世界市場(Global Synthetic Biology Industry)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆